Skip to content

A prospective cohort study of "neck seven-line acupuncture" for the treatment of sudden hearing loss based on the real world data and exploring the fMRI brain effect mechanism

A prospective cohort study of "neck seven-line acupuncture" for the treatment of sudden hearing loss based on the real world data and exploring the fMRI brain effect mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001359
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden hearing loss

Interventions

Exposure Group:Adjunctive acupuncture with the "neck seven-line acupuncture" based on conventional treatment

Sponsors

Dongzhimen Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria in the "Guidelines for Diagnosis and Treatment of Sudden Deafness (2015)" revised by the Editorial Board of the Chinese Journal of Otolaryngology Head and Neck Surgery and the Chinese Society of Otolaryngology Head and Neck Surgery and presenting as unilateral sudden deafness; (2) Age between 18 and 80 regardless of gender; (3) Complete clinical data with complete audiologic and other examination records.

Exclusion criteria

Exclusion criteria: (1) Sensorineural hearing loss due to other causes such as: presbycusis drug-induced hearing loss noise-induced hearing loss traumatic hearing loss autoimmune sensorineural hearing loss acoustic neuroma Meniere's disease and hearing loss caused by specific infections etc.; (2) Rule out congenital developmental abnormalities such as inner ear malformation and cochlear nerve hypoplasia; (3) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Change in pure-tone average hearing threshold from baseline at Week 2 of treatment;

Secondary

MeasureTime frame
Total effective rate during the second week of treatment and 1 month, 3 months, 6 months after treatment completion, final hearing thresholds in pure tone audiometry, specific changes at different frequencies in pure tone audiometry, and average improvement level in patients whose hearing improved;Change in vertebrobasilar hemodynamics during the second week of treatment compared to baseline;Adverse Event;The change in pure tone average hearing threshold 1 month 3 months and 6 months after treatment compared to baseline;Observe the changes in ALFF and ReHo values in the resting-state fMRI at week 2 of treatment compared to baseline;Changes in Tinnitus Evaluation Questionnaire (TEQ) scores at week 2 of treatment and 1 month 3 months and 6 months after treatment completion compared to baseline;

Countries

China

Contacts

Public ContactBaiPeng

Beijing University of Chinese Medicine

baipeng1978@163.com15810498777

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026